IRIDEX Net Worth
IRIDEX Net Worth Breakdown | IRIX |
IRIDEX Net Worth Analysis
IRIDEX's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including IRIDEX's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of IRIDEX's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform IRIDEX's net worth analysis. One common approach is to calculate IRIDEX's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares IRIDEX's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing IRIDEX's net worth. This approach calculates the present value of IRIDEX's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of IRIDEX's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate IRIDEX's net worth. This involves comparing IRIDEX's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into IRIDEX's net worth relative to its peers.
Enterprise Value |
|
To determine if IRIDEX is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding IRIDEX's net worth research are outlined below:
| IRIDEX may become a speculative penny stock | |
| IRIDEX had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 48.67 M. Net Loss for the year was (8.91 M) with profit before overhead, payroll, taxes, and interest of 20.1 M. | |
| IRIDEX currently holds about 17.97 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12. | |
| Roughly 28.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: What analysts say about IRIDEX Corporation stock - Free Expert Stock Watchlist - Autocar Professional |
IRIDEX Quarterly Good Will |
|
IRIDEX uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in IRIDEX. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to IRIDEX's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know IRIDEX's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IRIDEX is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IRIDEX backward and forwards among themselves. IRIDEX's institutional investor refers to the entity that pools money to purchase IRIDEX's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of New York Mellon Corp | 2025-03-31 | 31.5 K | Northern Trust Corp | 2025-03-31 | 25.2 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 14.5 K | Xtx Topco Ltd | 2025-03-31 | 10.3 K | Hightower Advisors, Llc | 2025-03-31 | 10 K | Tower Research Capital Llc | 2025-03-31 | 6 K | Ubs Group Ag | 2025-03-31 | 1.5 K | Group One Trading, Lp | 2025-03-31 | 1.1 K | West Paces Advisors Inc | 2025-03-31 | 135 | Paragon Assoc & Paragon Assoc Ii Jv | 2025-03-31 | 1000 K | Vanguard Group Inc | 2025-03-31 | 594.8 K |
Follow IRIDEX's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.69 M.Market Cap |
|
Project IRIDEX's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.19) | (0.18) | |
| Return On Capital Employed | (0.25) | (0.27) | |
| Return On Assets | (0.18) | (0.17) | |
| Return On Equity | (0.44) | (0.46) |
When accessing IRIDEX's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures IRIDEX's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of IRIDEX's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in IRIDEX's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of IRIDEX. Check IRIDEX's Beneish M Score to see the likelihood of IRIDEX's management manipulating its earnings.
Evaluate IRIDEX's management efficiency
IRIDEX has return on total asset (ROA) of (0.0954) % which means that it has lost $0.0954 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0693) %, meaning that it created substantial loss on money invested by shareholders. IRIDEX's management efficiency ratios could be used to measure how well IRIDEX manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.18 in 2025. Return On Capital Employed is likely to drop to -0.27 in 2025. At this time, IRIDEX's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.5 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 4.5 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.08 | 1.03 | |
| Tangible Book Value Per Share | 0.90 | 0.85 | |
| Enterprise Value Over EBITDA | (3.26) | (3.10) | |
| Price Book Value Ratio | 1.86 | 2.08 | |
| Enterprise Value Multiple | (3.26) | (3.10) | |
| Price Fair Value | 1.86 | 2.08 | |
| Enterprise Value | 22.9 M | 21.7 M |
The operational strategies employed by IRIDEX management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Enterprise Value Revenue 0.4452 | Revenue | Quarterly Revenue Growth 0.011 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRIDEX insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRIDEX's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRIDEX insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IRIDEX time-series forecasting models is one of many IRIDEX's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IRIDEX's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
IRIDEX Earnings per Share Projection vs Actual
IRIDEX Corporate Management
| Leigh Salvo | Head Relations | Profile | |
| Patrick Mercer | Chief Officer | Profile | |
| Fuad Ahmad | Interim Officer | Profile | |
| Bassem BouHabib | Vice Sales | Profile | |
| Romeo Dizon | Chief Officer | Profile |
Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.